Thromboembolism Risk In Pregnant Oncology Patients

Thromboembolism Risk In Pregnant Oncology Patients Overview This systematic review and meta-analysis investigated the incidence of venous thromboembolism (VTE) in pregnant individuals with active malignancy compared to those without malignancy. The study, based on seven cohort studies encompassing 5,928 individuals with both active malignancy and pregnancy, yielded the following key findings:  

Ibrutinib Treatment In Waldenström Macroglobulinemia

Ibrutinib Treatment In Waldenström Macroglobulinemia Waldenström macroglobulinemia (WM) is a rare type of non-hogdkins lymphoma driven by the gene mutation MYD88L265P. Ibrutinib, the first approved treatment, is effective but can cause side effects. A study found that 27% of WM patients needed to reduce Ibrutinib doses due to side effects like

Acute Myeloid Leukemia And Diverse Patient Survival Outcomes

Acute Myeloid Leukemia And Diverse Patient Survival Outcomes Background Cancer remains a prominent global health concern, accounting for a significant number of cases and fatalities worldwide in 2020, with projections indicating further increases in both incidence and mortality rates, particularly in the United States. Hematologic malignancies (HMs) constitute a substantial subset of

Maternal Migraines And Associated Pediatric Cancers

Maternal Migraines And Associated Pediatric Cancers Overview Maternal migraines are seen to be associated with unfavorable birth outcomes such as congenital malformations in babies, preterm births and infant low birth weight. It has been hypothesized that these unfavorable or adverse birth outcomes may be due to the intake of certain medications during

Hodgkin’s Lymphoma: A Case Study with Nystagmus and Diplopia

Hodgkin's Lymphoma: A Case Study with Nystagmus and Diplopia INTRODUCTION Paraneoplastic neurologic syndromes (PNS) are uncommon but important clinical situations caused by cancer, but not a direct result of tumor invasion. As compared to solid tumors, the chances of association of PNS with lymphomas are quite low. However, Hodgkin's and non-Hodgkin's lymphomas,

Thromboembolism Risk In Pregnant Oncology Patients